CRON Key Statistics, Chart & Performance
The current stock price of CRON is 3.05 USD. In the past month the price increased by 24.49%. In the past year, price increased by 56.41%.
CRON Latest News, Press Relases and Analysis
CRON Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 48.3 | 1.00T | ||
| JNJ | JOHNSON & JOHNSON | 20.63 | 516.00B | ||
| MRK | MERCK & CO. INC. | 11.38 | 248.85B | ||
| PFE | PFIZER INC | 8.26 | 150.27B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.28 | 110.52B | ||
| ZTS | ZOETIS INC | 19.08 | 53.31B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.37 | 22.24B | ||
| VTRS | VIATRIS INC | 5 | 13.43B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.6 | 10.78B | ||
| CORT | CORCEPT THERAPEUTICS INC | 99.2 | 9.18B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.37B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 4.97B |
Related stock screener links
About CRON
Company Profile
Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The firm distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
Company Info
CRONOS GROUP INC
4491 Concession Rd 12
TORONTO ONTARIO M5V 2H1 CA
CEO: Kurt Schmidt
Employees: 626
Phone: 14165040004
CRONOS GROUP INC / CRON FAQ
What does CRON do?
Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The firm distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
What is the current price of CRON stock?
The current stock price of CRON is 3.05 USD. The price decreased by -6.73% in the last trading session.
Does CRONOS GROUP INC pay dividends?
CRON does not pay a dividend.
How is the ChartMill rating for CRONOS GROUP INC?
CRON has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
On which exchange is CRON stock listed?
CRON stock is listed on the Nasdaq exchange.
What is the GICS sector and industry of CRON stock?
CRONOS GROUP INC (CRON) operates in the Health Care sector and the Pharmaceuticals industry.
Can you provide the short interest for CRON stock?
The outstanding short interest for CRONOS GROUP INC (CRON) is 1.67% of its float.
CRON Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to CRON. When comparing the yearly performance of all stocks, CRON is one of the better performing stocks in the market, outperforming 90.6% of all stocks.
CRON Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CRON. No worries on liquidiy or solvency for CRON as it has an excellent financial health rating, but there are worries on the profitability.
CRON Financial Highlights
Over the last trailing twelve months CRON reported a non-GAAP Earnings per Share(EPS) of 0.11. The EPS increased by 283.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.27% | ||
| ROA | 3.06% | ||
| ROE | 3.33% | ||
| Debt/Equity | 0 |
CRON Forecast & Estimates
7 analysts have analysed CRON and the average price target is 3.64 USD. This implies a price increase of 19.3% is expected in the next year compared to the current price of 3.05.
For the next year, analysts expect an EPS growth of -115.3% and a revenue growth 12.95% for CRON